OUTLOOK THERAPEUTICS Trademark

Trademark Overview

On Tuesday, November 20, 2018, a trademark application was filed for OUTLOOK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OUTLOOK THERAPEUTICS trademark a serial number of 88201817. The federal status of this trademark filing is REGISTERED as of Tuesday, August 23, 2022. This trademark is owned by Oncobiologics, Inc.. The OUTLOOK THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; provision of medical research and scientific research services and information in the field of pharmaceuticals, biologics, biosimilar drugs, and clinical trials
outlook therapeutics

General Information

Serial Number88201817
Word MarkOUTLOOK THERAPEUTICS
Filing DateTuesday, November 20, 2018
Status700 - REGISTERED
Status DateTuesday, August 23, 2022
Registration Number6827946
Registration DateTuesday, August 23, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2019

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development; provision of medical research and scientific research services and information in the field of pharmaceuticals, biologics, biosimilar drugs, and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 10, 2018
Primary Code042
First Use Anywhere DateTuesday, December 18, 2018
First Use In Commerce DateTuesday, December 18, 2018

Trademark Owner History

Party NameOUTLOOK THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIselin, NJ 08830
Party NameOUTLOOK THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressIselin, NJ 08830
Party NameOncobiologics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512
Party NameOncobiologics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events

Event DateEvent Description
Friday, November 23, 2018NEW APPLICATION ENTERED
Monday, December 10, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 22, 2019ASSIGNED TO EXAMINER
Tuesday, February 26, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 26, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, February 26, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 26, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, February 27, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 22, 2019ASSIGNED TO LIE
Friday, March 22, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 30, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 25, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 18, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, December 20, 2019SOU TEAS EXTENSION RECEIVED
Friday, December 20, 2019SOU EXTENSION 1 FILED
Wednesday, January 1, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, January 6, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 6, 2020SOU EXTENSION 1 GRANTED
Tuesday, January 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 9, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 9, 2020SOU EXTENSION 2 FILED
Tuesday, June 9, 2020SOU EXTENSION 2 GRANTED
Thursday, June 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 10, 2020SOU TEAS EXTENSION RECEIVED
Thursday, December 10, 2020SOU EXTENSION 3 FILED
Thursday, December 10, 2020SOU EXTENSION 3 GRANTED
Tuesday, December 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, June 20, 2021SOU TEAS EXTENSION RECEIVED
Sunday, June 20, 2021SOU EXTENSION 4 FILED
Sunday, June 20, 2021SOU EXTENSION 4 GRANTED
Tuesday, June 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 17, 2021SOU TEAS EXTENSION RECEIVED
Friday, December 17, 2021SOU EXTENSION 5 FILED
Monday, January 3, 2022SOU EXTENSION 5 GRANTED
Tuesday, January 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 27, 2022TEAS STATEMENT OF USE RECEIVED
Monday, June 27, 2022USE AMENDMENT FILED
Thursday, June 30, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 21, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 22, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 23, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 23, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, March 19, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 19, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 19, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, March 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

therapeutics outlook research biologics pharmaceuticals biosimilar clinical trials field drugs information provision